According to a new cardiac surgery market study by iData Research, the number of cardiac surgeries exceeds 900,000 procedures each year in the United States with projections for the number to reach 1.3M by 2029. The US Cardiac surgery market is growing rapidly driven by the growth of many underlying procedures. The number of cardiac

Introduction The U.S. cardiac surgery market is a critical sector in the healthcare industry, responsible for providing innovative solutions to patients with heart conditions. In 2022, three prominent companies, Edwards Lifesciences, Abbott, and Medtronic, stood out as the top competitors in this market. Each of these companies has strategically positioned itself within various segments of

In the ever-evolving landscape of healthcare, innovations and advancements continue to shape the way we approach patient care. One such transformation is occurring in the U.S. Vascular Access Device (VAD) Market, where a notable shift towards less expensive catheters is taking place. This transition is driven by a combination of concerns associated with traditional vascular

The European Infusion Therapy Device Market demonstrates resilience in the face of economic uncertainties across the continent. Despite an impending recession, the market continues to grow steadily, driven by strong market drivers. In our blog, we delve into the factors propelling this growth, providing valuable insights on how businesses can leverage these drivers for success.

The Global Interventional Cardiology Device Market is poised to achieve a remarkable value of $13 billion by 2029. Despite the anticipated decline in prices over the forecast period, primarily driven by market consolidation and bundling, the market is experiencing steady growth and expansion. Developing countries have witnessed an improvement in healthcare accessibility and overall hospital

With the rising costs of healthcare, many patients are seeking treatment outside of hospitals, including in outpatient settings such as homecare and specialty clinics. As a result, the infusion therapy device market has experienced significant growth. Despite the increased cost per device due to lower purchasing power at these alternate care sites, demand for premium

HeartFlow, a California-based start-up that has developed artificial intelligence to diagnose and provide information on coronary artery disease (CAD) based on CT scans, has recently received a $215M financing round led and participated by Bain Capital Life Sciences. The company’s revolutionary products have gained FDA approval, with its first product receiving De Novo clearance in

The field of cardiac rhythm management and ablation is rapidly evolving with the emergence of new technologies. Over the past decade, there have been significant improvements in the capabilities and battery lifespan of pacemakers and ICDs. However, the advancements in this field are far from over. In the coming years, wireless technology is expected to

Last year, more than 215,000 neuromodulation procedures were performed worldwide, with expectations that this number will climb to nearly 400,000 by 2029. Furthermore, it is expected that the market value will increase significantly from $4.9 billion to $8.2 billion during that same period. So, what’s driving this impressive market growth? Our latest global neurological devices

The European interventional cardiology market witnessed a minor decline in 2022 compared to the previous year, primarily attributed to low unit sales growth and extensive price erosion. This trend is expected to continue throughout the projected period, resulting in a slight contraction of the market by 2029. Despite the availability of numerous innovative devices, the

Vascular access devices are becoming increasingly popular in the United States. However, during the COVID-19 pandemic, the quantity of units purchased decreased, and this trend continued into 2022. Nevertheless, the market is anticipated to experience growth in 2023 and beyond, driven by various factors, including government policies that promote safer practices and products. Within our

Pulsed Field Ablation (PFA) is a promising new technology in the medical field, and its popularity is on the rise. PFA uses controlled, pulsed electric fields to disrupt irregular electrical pathways in the heart that cause conditions like atrial fibrillation (AF). This innovative approach is expected to offer a safer and more effective alternative to

Register to receive a free Interventional Cardiology Devices Market Report Suite for U.S. 2023-2029 synopsis and brochure Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and treatment options. Devices for the diagnosis and treatment of CAD can be of high volume and low cost or of a relatively low

Globally, the electrophysiology and cardiac ablation catheter markets are growing at a steady pace. Individually, the diagnostic electrophysiology (EP) catheter market value is increasing into 2028, and iData’s analysts predict that the market will reach $3.1 billion. Similarly, the cardiac ablation catheter market is growing and is approaching nearly $5 billion by 2028.  What Segments

Located between the left ventricle and the aorta, sits an essential valve known as the aortic heart valve. Typically, problems associated with the valves are designated as either aortic stenosis and aortic insufficiency. Aortic stenosis occurs when the aortic valve narrows to the point where blood flow is decreased and impeded upon. On the other

WHAT ARE VASCULAR ACCESS DEVICES? A vascular access device is a medical device that’s purpose is to access a patient’s veins and arteries. Additionally, vascular access accessories are used to improve safety and overall performance. Catheters are one of the main vascular access devices used and their indications for use include the administration of drugs,

Throughout iData’s MedSKU analysis on the U.S. pacemaker market, five companies, over 40 brands, and 45 SKUs were analyzed. Despite many market segments included in the MedSKU analysis, this blog focuses and dives deep into three specific segments: Single-Chamber Pacemakers Dual-Chamber Pacemaker  Leadless Pacemakers  iData’s recently completed MedSKU analysis includes an overview of the companies,

As part of a pivotal clinical study, Abbott officially announced the world’s first patient implants of a dual-chamber leadless pacemaker, aptly named AVEIR DRi2i™. This implant of the investigational Aveir™ represents a technological milestone for leadless pacing and is the first seen within the trial.  Patients who experience a slower heart rate are eligible to

iData’s full report suite on the global market for autotransfusion devices includes disposable materials and capital equipment. Disposable devices are typically sold in a kit and can include a wash kit, suction/anticoagulant line and a blood collection reservoir. The capital equipment market includes autotransfusion machines. Overall, the global autotransfusion device market was valued at $224.9

With consideration of pandemic strains on healthcare systems worldwide, seven centers in the U.S., U.K., and Canada have opted to attempt same-day discharge (SDD) with hopes of maintaining transcatheter aortic valve replacement (TAVR) volumes whilst preserving hospital resources during COVID-19 case surges. According to MedPage, after a 17 month trial, 5.9% of 2,100 patients who

When the mitral valve prolapses, blood leaks back into the atrium each time the heart beats. This condition, aptly named degenerative mitral regurgitation (DMR), can be asymptomatic for many patients, but for some it may cause fainting, pain, shortness of breath, and more. According to the University of Maryland, In a year, less than 2

Register to receive the complimentary U.S. Market Report Suite for Cardiac Rhythm Management Devices – MedSuite report synopsis and brochure As it is said in the medical industry: new year, new CPT codes. With each new year, medical professionals are given a handful of changes to the list of CPT codes, and with regard to the

Overall, the global vascular access device market was valued at $4.2 billion, with around 1 billion vascular access devices placed each year. The market size is expected to increase over the forecast period and reach $4.8 billion in 2026. HOW ARE VASCULAR ACCESS DEVICES USED? iData’s global market report for vascular access devices includes both

iData’s analysts work extensively to retrieve data and source both syndicated and custom market research reports. Owing to their in-depth understanding of the markets and first-hand experience with the appropriate data, our analysts have curated a detailed analysis on the market drivers of the Cardiac Surgery Market. With this top-down insight of our global report,

iData’s full report on the Global Interventional Cardiology Market includes in-depth information on the following segments: Coronary Atherectomy Devices Catheters Guidewires Introducer Sheaths Vascular Closure Balloon Inflation CEP Devices Overall, the global pandemic (COVID-19) resulted in a substantial decline in the global interventional cardiology market. The global interventional cardiology market, as most medical device markets,

Market trends for the global Left Atrial Appendage (LAA) Closure Device Market indicate growth over the forecast period and into 2027. Overall, the global LAA market had a valuation of approximately $697 million in 2020. Due to the global COVID-19 pandemic, the LAA market experienced a significant decrease in revenue between 2019 and 2020. Despite

2020 was an unusual year mainly because of the global COVID-19 pandemic, which caused a decrease in the Global Atherectomy Market from 2019 to 2020. While the value of the total atherectomy device market decreased in 2020, due primarily to COVID-19, iData forecasts that the market is expected to grow over the forecast period following

iData’s report on the global central venous catheter (CVC) market includes both acute and chronic CVC’s. In the past, the central venous catheter market suffered extreme consequences after the Joint Commission guidelines recommended that catheters should only be placed in the femoral vein if no other sites are available. This recommendation was due to the

Throughout iData’s MedSKU analysis, six companies and over 30 brands were analyzed within six market segments including IVUS consoles, IVUS catheters, OCT consoles, OCT catheters, FFR consoles, and FFR catheters. Despite many market segments included in the MedSKU analysis, this blog focuses and dives deep into three specific segments: Intravascular Ultrasound (IVUS) Catheters  Fractional Flow

iData’s report on the global peripheral vascular stents market covers bare-metal stents (BMS), covered stents, and drug-eluting stents (DES). In 2018, the drug-eluting stent market suffered extreme consequences after studies demonstrating the late-mortality signal from paclitaxel use within the peripheries were released. Although the FDA released a statement approving the use of paclitaxel devices, many